Spots Global Cancer Trial Database for survivin
Every month we try and update this database with for survivin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Development of Immunological Assays for the Evaluation of Tumor Antigen Specific Immunity | NCT02016833 | Ovarian Serous ... Undifferentiate... Cervical Cancer Cervical Intrae... Acute Myeloid L... Chronic Myeloid... | Blood Sampling | 18 Years - 70 Years | PX Biosolutions | |
| Significance of Immunohistochemical Expression of Survivin in Renal Cell Carcinoma | NCT04873180 | Renal Cell Carc... | sectioning and ... | 30 Years - 70 Years | Sohag University | |
| Apoptotic Signaling Pathways in Rats With Endometrial Hyperplasia | NCT02872818 | Apoptotic Signa... | 17β estradiol h... Metformin medroxyprogeste... | 8 Weeks - 10 Weeks | Kayseri Education and Research Hospital | |
| Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors | NCT03836352 | Ovarian Cancer Hepatocellular ... Non-small Cell ... Bladder Cancer Microsatellite ... | DPX-Survivac Cyclophosphamid... Pembrolizumab | 18 Years - | ImmunoVaccine Technologies, Inc. (IMV Inc.) | |
| Carboplatin as a Radiosensitizer in Treating Childhood Ependymoma | NCT01088035 | Ependymoma | Carboplatin | 12 Months - 21 Years | Ann & Robert H Lurie Children's Hospital of Chicago | |
| EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) | NCT01186328 | Lymphoblastic L... Lymphoblastic L... Leukemia, Lymph... Leukemia, Lymph... | EZN-3042 Cytarabine Doxorubicin Prednisone Vincristine PEG-asparaginas... Methotrexate Hydrocortisone | 1 Year - 21 Years | Therapeutic Advances in Childhood Leukemia Consortium | |
| Phase 1 Study of Terameprocol (EM-1421) in Patients With Leukemia | NCT00664677 | Leukemias Acute Myeloid L... Acute Lymphocyt... Adult T Cell Le... Chronic Myeloid... Chronic Lymphoc... Myelodysplastic... Chronic Myelomo... | Terameprocol (E... | 18 Years - | Erimos Pharmaceuticals | |
| Survivin Peptide Vaccination for Patients With Advanced Melanoma, Pancreatic, Colon and Cervical Cancer | NCT00108875 | Malignant Melan... Pancreatic Canc... Colon Cancer Cervical Cancer | Survivin peptid... | 19 Years - 90 Years | Julius-Maximilians University | |
| Blood and Cerebrospinal Fluid for Pediatric Brain Tumor Research | NCT01556178 | Hydrocephalus | 1 Year - 21 Years | Ann & Robert H Lurie Children's Hospital of Chicago | ||
| Significance of Immunohistochemical Expression of Survivin in Renal Cell Carcinoma | NCT04873180 | Renal Cell Carc... | sectioning and ... | 30 Years - 70 Years | Sohag University | |
| EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) | NCT01186328 | Lymphoblastic L... Lymphoblastic L... Leukemia, Lymph... Leukemia, Lymph... | EZN-3042 Cytarabine Doxorubicin Prednisone Vincristine PEG-asparaginas... Methotrexate Hydrocortisone | 1 Year - 21 Years | Therapeutic Advances in Childhood Leukemia Consortium | |
| Development of Immunological Assays for the Evaluation of Tumor Antigen Specific Immunity | NCT02016833 | Ovarian Serous ... Undifferentiate... Cervical Cancer Cervical Intrae... Acute Myeloid L... Chronic Myeloid... | Blood Sampling | 18 Years - 70 Years | PX Biosolutions | |
| A Phase I/II Study of Paclitaxel, Carboplatin and YM155 (Survivin Suppressor) in Subjects With Solid Tumors (Phase I) and Advanced Non-Small Cell Lung Carcinoma (Phase II) | NCT01100931 | NSCLC Solid Tumors | YM155 Carboplatin Paclitaxel | 18 Years - | National Institutes of Health Clinical Center (CC) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
